Matthew Weir
Overview
Explore the profile of Matthew Weir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCoy I, Go A, Hsu J, Zhang X, Muiru A, Shah V, et al.
J Am Soc Nephrol
. 2025 Mar;
PMID: 40067355
Background: Cystatin C has entered mainstream clinical care as a measure of kidney function, joining serum creatinine which has been used for almost a century. But many physicians notice that...
2.
Harel Z, Smyth B, Badve S, Blum D, Beaubien-Souligny W, Silver S, et al.
J Am Soc Nephrol
. 2024 Nov;
PMID: 39495569
No abstract available.
3.
Rajagopalan S, Dobre M, Dazard J, Vergara-Martel A, Connelly K, Farkouh M, et al.
Circulation
. 2024 Aug;
150(9):663-676.
PMID: 39129649
Background: Persistent mineralocorticoid receptor activation is a pathologic response in type 2 diabetes and chronic kidney disease. Whereas mineralocorticoid receptor antagonists are beneficial in reducing cardiovascular complications, direct mechanistic pathways...
4.
Wald R, Gaudry S, da Costa B, Adhikari N, Bellomo R, Du B, et al.
Intensive Care Med
. 2023 Oct;
49(11):1305-1316.
PMID: 37815560
Background: There is controversy regarding the optimal renal-replacement therapy (RRT) modality for critically ill patients with acute kidney injury (AKI). Methods: We conducted a secondary analysis of the STandard versus...
5.
Babroudi S, Tighiouart H, Schrauben S, Cohen J, Fischer M, Rahman M, et al.
Am J Kidney Dis
. 2023 May;
82(4):443-453.e1.
PMID: 37245689
Rationale & Objective: Hypertension is a known risk factor for dementia and cognitive impairment. There are limited data on the relation of systolic blood pressure (SBP) and diastolic blood pressure...
6.
Bagshaw S, Serpa Neto A, Smith O, Weir M, Qiu H, Du B, et al.
Intensive Care Med
. 2023 Feb;
49(3):381-383.
PMID: 36757471
No abstract available.
7.
Taliercio J, Nakhoul G, Mehdi A, Yang W, Sha D, Schold J, et al.
Kidney Med
. 2022 Nov;
4(11):100547.
PMID: 36339663
Rationale And Objective: Chronic kidney disease is a risk enhancing factor for cardiovascular disease (CVD) and mortality, and the role of aspirin use is unclear in this population. We investigated...
8.
Bagshaw S, Serpa Neto A, Smith O, Weir M, Qiu H, Du B, et al.
Intensive Care Med
. 2022 Nov;
48(12):1736-1750.
PMID: 36331570
Purpose: To assess whether pre-existing chronic kidney disease (CKD) modified the relationship between the strategy for renal-replacement theraphy (RRT) initiation and clinical outcomes in the STARRT-AKI trial. Methods: This was...
9.
Adams P, Richard L, Weir M, Speechley M
Can Liver J
. 2022 Aug;
4(4):381-390.
PMID: 35989887
Background: We report long-term survival and development of selected health conditions in Ontario-based referred and screened C282Y homozygotes for hemochromatosis treated by phlebotomy compared with an untreated control group known...
10.
Butler J, Anker S, Siddiqi T, Coats A, Dorigotti F, Filippatos G, et al.
Eur J Heart Fail
. 2021 Nov;
24(1):230-238.
PMID: 34800079
Aims: In patients with current or a history of hyperkalaemia, treatment with renin-angiotensin-aldosterone system inhibitors (RAASi) is often compromised. Patiromer, a novel potassium (K ) binder, may improve serum K...